JANX
Price
$27.30
Change
-$0.95 (-3.36%)
Updated
Apr 3, 02:45 PM (EDT)
Capitalization
1.67B
40 days until earnings call
SKYE
Price
$1.43
Change
+$0.03 (+2.14%)
Updated
Apr 2 closing price
Capitalization
44.29M
Ad is loading...

JANX vs SKYE

Header iconJANX vs SKYE Comparison
Open Charts JANX vs SKYEBanner chart's image
Janux Therapeutics
Price$27.30
Change-$0.95 (-3.36%)
Volume$100
Capitalization1.67B
Skye Bioscience
Price$1.43
Change+$0.03 (+2.14%)
Volume$103.32K
Capitalization44.29M
JANX vs SKYE Comparison Chart
Loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JANX vs. SKYE commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANX is a Hold and SKYE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (JANX: $28.25 vs. SKYE: $1.43)
Brand notoriety: JANX and SKYE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JANX: 83% vs. SKYE: 47%
Market capitalization -- JANX: $1.67B vs. SKYE: $44.29M
JANX [@Biotechnology] is valued at $1.67B. SKYE’s [@Biotechnology] market capitalization is $44.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JANX’s FA Score shows that 0 FA rating(s) are green whileSKYE’s FA Score has 1 green FA rating(s).

  • JANX’s FA Score: 0 green, 5 red.
  • SKYE’s FA Score: 1 green, 4 red.
According to our system of comparison, SKYE is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JANX’s TA Score shows that 4 TA indicator(s) are bullish while SKYE’s TA Score has 4 bullish TA indicator(s).

  • JANX’s TA Score: 4 bullish, 3 bearish.
  • SKYE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JANX is a better buy in the short-term than SKYE.

Price Growth

JANX (@Biotechnology) experienced а -6.21% price change this week, while SKYE (@Biotechnology) price change was -37.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.05%. For the same industry, the average monthly price growth was -10.17%, and the average quarterly price growth was -14.28%.

Reported Earning Dates

JANX is expected to report earnings on May 13, 2025.

SKYE is expected to report earnings on Nov 29, 2023.

Industries' Descriptions

@Biotechnology (-8.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.67B) has a higher market cap than SKYE($44.3M). JANX (-47.236) and SKYE (-49.470) have similar YTD gains . SKYE has higher annual earnings (EBITDA): -19.64M vs. JANX (-96.79M). JANX has more cash in the bank: 1.03B vs. SKYE (67.4M). SKYE has less debt than JANX: SKYE (191K) vs JANX (23M). JANX has higher revenues than SKYE: JANX (10.6M) vs SKYE (0).
JANXSKYEJANX / SKYE
Capitalization1.67B44.3M3,770%
EBITDA-96.79M-19.64M493%
Gain YTD-47.236-49.47095%
P/E RatioN/A3.57-
Revenue10.6M0-
Total Cash1.03B67.4M1,521%
Total Debt23M191K12,042%
FUNDAMENTALS RATINGS
SKYE: Fundamental Ratings
SKYE
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JANXSKYE
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGRIX78.79N/A
N/A
JPMorgan US Value A
CBSAX21.35N/A
N/A
Columbia Select Mid Cap Growth Fund A
NWHQX27.66N/A
N/A
Nationwide Bailard Tech & Sci M
GLVYX78.41N/A
N/A
Invesco Global Focus Y
AZMCX16.26N/A
N/A
Virtus NFJ Emerging Markets Value C

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+5.37%
DNLI - JANX
46%
Loosely correlated
+11.80%
SKYE - JANX
41%
Loosely correlated
+2.14%
LGND - JANX
39%
Loosely correlated
+3.73%
OCUL - JANX
37%
Loosely correlated
+12.23%
NUVB - JANX
36%
Loosely correlated
+2.29%
More

SKYE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SKYE has been loosely correlated with CRBP. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if SKYE jumps, then CRBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SKYE
1D Price
Change %
SKYE100%
+2.14%
CRBP - SKYE
45%
Loosely correlated
+3.38%
JANX - SKYE
40%
Loosely correlated
+5.37%
VKTX - SKYE
34%
Loosely correlated
+7.40%
DNLI - SKYE
28%
Poorly correlated
+11.80%
PGEN - SKYE
27%
Poorly correlated
+3.14%
More